An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha
Clinical trial NCT00171223 · COMPLETED
Trial details
- NCT number
- NCT00171223
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-06
- Primary completion
- 2013-11-29
- Enrollment
- 532
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.